January 04, 2021 06:46 PM IST
The Drug Controller General of India (DCGI) on January 3 granted permission for restricted emergency use of the AstraZeneca-Oxford University and Bharat Biotech Covid-19 vaccines. The approval was based on the recommendations of the Subject Expert Committee (SEC), which reviewed the data on safety and immunogenicity of the two vaccines. However, post the announcement it is India’s indigenous vaccine which has found itself in the middle of a controversy. Here’s why. January 01, 2021 05:18 PM IST
All calls from Reliance Jio to other networks in India to be free from January 1, as the Interconnect Usage Charge (IUC) regime ends. Moneycontrol s Sakshi Batra does a 3 -Point Analysis to find out what this means for the industry at large
Bulk drug manufacturer, Bajaj Healthcare, had a robust Q3 with profits more than tripling to Rs 26 crore. Here s a detailed analysis of Bajaj s Q3 performance, its future outlook and whether investors should keep the stock on their radar March 23, 2021 09:16 PM IST
Gabriel India is the leading supplier of shock absorbers & front forks to all major manufacturers of 2,3 & 4 wheelers in India. A shift in preference towards personal transport as people continue to be cautious about taking public vehicles is a key growth trigger for Gabriel as it generates more than 89% of its revenues from these segments. It has launched 11 product lines which received a positive market response. The company sees significant opportunities in export markets as US and the European OEMs have started reducing their dependence on Chinese manufacturers for component supplies. The company has established itself as a strong player in the global market. Watch the video for more updates